查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1629263

週边干预市场，按产品类型、程序、最终用途、国家和地区 - 2025-2032 年全球行业分析、市场规模、市场份额和预测

Peripheral Interventions Market, By Product Type, By Procedure, By End-Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 384 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2024年外围干预市场规模为96.7834亿美元，2025年至2032年复合年增长率为9.1%。

外围干预市场-市场动态

血管疾病盛行率上升推动市场成长

血管疾病盛行率的上升是推动週边干预市场成长的重要因素。由于人口老化、久坐的生活方式以及糖尿病、吸烟和高血压等危险因素的增加，包括週边动脉疾病（PAD）、静脉曲张和深部静脉栓塞（DVT）在内的血管疾病变得越来越常见。据世界卫生组织 (WHO) 称，心血管疾病 (CVD) 是全球死亡的主要原因，估计占所有死亡的 32%，其中很大一部分归因于週边血管疾病。随着血管疾病变得越来越普遍，对有效、微创治疗方案的需求也日益增长。支架、血管成形球囊和导管等周边介入设备提供了一种解决方案，可实现快速、精确的治疗，改善血流、缓解症状并预防截肢或中风等严重併发症。随着医疗保健系统致力于解决日益增加的血管疾病负担，预计对这些干预措施的需求将会增加。此外，医疗技术的进步不断使周边干预变得更安全、更有效、侵入性更小，进一步推动了这些设备在血管疾病治疗中的采用。盛行率的增加和医疗创新的结合预计将在未来几年推动週边干预市场的显着成长。

外围干预市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球市场在预测期内（2025-2032 年）每年将以 9.1% 左右的复合年增长率成长
  • 根据产品类型细分，预计支架将在 2024 年呈现最大市场份额
  • 根据最终用途细分，医院将成为 2024 年的主导职能
  • 按地区划分，北美是 2024 年的主要收入来源

外围干预市场細項分析：

全球週边干预市场根据产品类型、程序、最终用途和地区进行细分。

根据产品类型，市场分为五类：支架、导管、导丝、球囊和血管闭合装置。支架在市场上占据主导地位，因为它们已被证明可以透过保持动脉畅通来恢復血流，这使其成为週边动脉疾病 (PAD) 等疾病的关键解决方案。此外，药物洗脱支架和生物可吸收支架等支架技术的进步提高了它们的安全性、性能和患者治疗效果，推动了它们的广泛采用。

根据最终用途，市场分为三类：医院、专科诊所和门诊手术中心。医院凭藉其先进的医疗基础设施、专业的电生理学实验室以及处理复杂和大容量手术的能力而占据市场主导地位。此外，医院提供全面的护理，包括术前和术后监测，使其成为需要周边介入治疗的患者的首选场所。

外围干预市场 - 地理洞察

北美拥有最大的市场份额，主要是由于血管疾病的高盛行率、人口老化和先进的医疗基础设施。尤其是在对微创手术的高需求和医疗技术不断进步的推动下，美国拥有完善的周边干预市场。

欧洲在市场上也发挥着至关重要的作用，德国、英国和法国等国家专注于采用创新的外围干预设备。欧洲市场受益于强有力的医疗保健政策、人们对血管疾病的认识不断提高以及先进治疗方法的普及。相较之下，在中国、印度和日本等国家庞大的患者群体、改善的医疗设施以及可支配收入增加的推动下，亚太地区正在经历最快的成长。随着这些国家与生活方式相关的疾病盛行率上升，对具有成本效益的微创治疗方案的需求不断增长。在拉丁美洲、中东和非洲，随着医疗保健系统的改善和对血管疾病的意识提高，週边干预市场正在逐渐扩大，为这些地区的市场成长和创新创造了新的机会。

週边介入市场-竞争格局：

週边干预市场竞争格局的特点是既有多家老牌企业，也有专注于创新和新产品开发的新兴公司。市场参与者基于产品品质、技术进步和策略合作伙伴关係进行竞争。领先的公司不断致力于增强其产品系列，包括药物洗脱支架、生物可吸收支架和先进的导管技术等功能，以改善患者的治疗效果并降低併发症的风险。这些创新旨在为治疗週边血管疾病提供更安全、更有效、更持久的解决方案。此外，公司还透过合併、收购以及与医疗机构的合作来扩大其市场份额，以扩大其地理覆盖范围并接触新的患者群体。另一个关键策略是强调具有成本效益的解决方案，特别是在新兴市场，在这些市场中，负担能力和可近性是推动采用的关键因素。监管批准和遵守严格的安全标准也是这一竞争格局中的关键差异化因素，因为公司必须适应复杂的监管环境才能推出新产品。正在进行的临床试验、研究和开发活动进一步塑造了竞争动态，这些活动的重点是增强设备性能和扩大周边干预的适应症。随着全球对先进微创治疗的需求不断增长，尤其是在血管疾病负担日益严重的地区，这种情况仍在不断发展。

最新进展：

  • 2024 年4 月，雅培突破性的可溶性支架Esprit BTK 系统获得FDA 批准用于治疗膝盖以下动脉，为患有慢性肢体威胁性缺血(CLTI) 和外周动脉疾病(PAD) 的患者提供了一种新的有效解决方案。这种创新装置会随着时间的推移而溶解，在改善结果和减少疾病进展方面优于传统的球囊血管成形术。
  • 2024 年 6 月，飞利浦推出了 Duo 静脉支架系统，这是一种突破性的医疗设备，旨在治疗慢性静脉功能不全 (CVI) 患者的症状性静脉流出阻塞。该装置已获得 FDA 的上市前批准，透过结合 Duo Hybrid 和 Duo Extend 两种支架来解决静脉解剖学的挑战，提供差异化设计以适应血管曲率并最大限度地减少支架併发症。该系统是飞利浦透过创新血管技术增强 CVI 治疗的更广泛策略的一部分。
  • 2024年11月，新的血管支架移植公司Solaris Endoangio在美国成立。该公司正在推出创新技术，旨在改善週边动脉疾病（PAD）治疗和透析通路的患者预后。此次发布标誌着一个重要的里程碑，因为 Solaris 旨在解决血管护理方面的关键差距，并专注于高品质、持久的解决方案，以防止再狭窄和改善长期血管通畅。

目录

第一章：外围干预市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的外围干预市场片段
    • 按程序分類的外围干预市场片段
    • 按最终用途分類的外围干预市场片段
    • 按国家/地区分類的周边干预市场片段
    • 按地区分類的周边干预市场片段
  • 竞争洞察

第 3 章：外围干预主要市场趋势

  • 外围干预市场驱动因素
    • 市场驱动因素的影响分析
  • 外围干预市场限制
    • 市场限制影响分析
  • 外围干预市场机会
  • 週边干预市场未来趋势

第 4 章：外围干预产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：外围干预市场：地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：外围干预市场格局

  • 2024 年外围干预市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：外围干预市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 支架
    • 导管
    • 导丝
    • 气球
    • 血管闭合装置

第 8 章：外围干预市场 - 按程序

  • 概述
    • 按程序分類的细分市场占有率分析
    • 血管成形术
    • 支架置入术
    • 旋切术
    • 溶栓

第 9 章：外周干预市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医院
    • 门诊手术中心 (ASC)
    • 专科诊所

第 10 章：外围干预市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 外围设备介入措施北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按程序）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 外围设备干预措施欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按程序）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 外围设备介入措施 亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 按程序分類的亚太地区市场规模和预测
    • 亚太地区市场规模和预测（按最终用途）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 外围干预措施 拉丁美洲的主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按程序）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 週边干预 中东和非洲主要製造商
    • MEA 市场规模和预测（按国家/地区）
    • MEA 市场规模和预测（按产品类型）
    • MEA 市场规模和预测（按程序）
    • MEA 市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 外围干预产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Abbott
    • Boston Scientific
    • Medtronic
    • Cook Medical
    • Cordis
    • Terumo Corporation
    • Johnson & Johnson
    • Teleflex
    • B. Braun Melsungen
    • Penumbra, Inc.
    • Endologix
    • Merit Medical Systems
    • Philips Healthcare
    • AngioDynamics
    • Siemens Healthineers
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4561

REPORT HIGHLIGHT

Peripheral Interventions Market size was valued at US$ 9,678.34 Million in 2024, expanding at a CAGR of 9.1% from 2025 to 2032.

Peripheral interventions refer to medical procedures that target the peripheral arteries, veins, or nerves outside the central body organs such as the brain and heart. These interventions typically involve minimally invasive techniques to treat conditions like peripheral artery disease (PAD), deep vein thrombosis (DVT), varicose veins, and other vascular disorders. They can include the use of devices such as stents, angioplasty balloons, catheters, or embolization coils, which are inserted into the body through small incisions or punctures. The need for peripheral intervention devices arises due to the increasing prevalence of lifestyle-related diseases such as diabetes, hypertension, and smoking, which contribute to vascular disorders. These devices help in restoring normal blood flow, alleviating symptoms, and improving the overall quality of life for patients. Peripheral interventions also offer several benefits over traditional open surgeries, including reduced recovery times, fewer complications, and minimal scarring. The importance of peripheral intervention devices lies in their ability to offer non-surgical, effective solutions to patients with vascular issues. By enabling quick intervention and precise treatment, these devices play a critical role in managing chronic conditions, preventing more serious complications like amputations or strokes, and improving patient outcomes in both short-term and long-term healthcare settings.

Peripheral Interventions Market- Market Dynamics

Rising Prevalence of vascular diseases to drive market growth

The rising prevalence of vascular diseases is a significant factor driving the growth of the peripheral interventions market. Vascular diseases, including peripheral artery disease (PAD), varicose veins, and deep vein thrombosis (DVT), are becoming more common due to an aging population, sedentary lifestyles, and an increase in risk factors such as diabetes, smoking, and hypertension. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for an estimated 32% of all deaths, with a significant portion attributed to peripheral vascular disorders. As vascular diseases become more widespread, there is a growing need for effective, minimally invasive treatment options. Peripheral intervention devices, such as stents, angioplasty balloons, and catheters, offer a solution by enabling quick and precise treatment that improves blood flow, alleviates symptoms, and prevents severe complications like limb amputations or strokes. The demand for these interventions is anticipated to rise as healthcare systems aim to address the rising burden of vascular diseases. In addition, advancements in medical technology continue to make peripheral interventions safer, more effective, and less invasive, further boosting the adoption of these devices in the treatment of vascular conditions. This combination of increasing prevalence and medical innovation is expected to drive significant growth in the peripheral interventions market in the coming years.

Peripheral Interventions Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2025-2032)
  • Based on Product Type segmentation, Stents was predicted to show maximum market share in the year 2024
  • Based on End-Use segmentation, Hospitals was the leading Function in 2024
  • Based on region, North America was the leading revenue generator in 2024

Peripheral Interventions Market- Segmentation Analysis:

The Global Peripheral Interventions Market is segmented based on Product Type, Procedure, End-Use and Region.

The market is divided into five categories based on Product Type: Stents, Catheters, Guidewires, Balloons, and Vascular Closure Devices. Stents dominate the market due to their proven effectiveness in restoring blood flow by keeping arteries open, making them a critical solution for conditions like peripheral artery disease (PAD). Additionally, advancements in stent technology, such as drug-eluting and bioresorbable stents, have enhanced their safety, performance, and patient outcomes, driving their widespread adoption.

The market is divided into three categories based on End-Use: Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Hospitals dominate the market due to their advanced medical infrastructure, availability of specialized electrophysiology labs, and ability to handle complex and high-volume procedures. Additionally, hospitals provide comprehensive care, including pre-and post-procedure monitoring, making them the preferred setting for patients requiring peripheral intervention treatments.

Peripheral Interventions Market- Geographical Insights

North America holds the largest market share, primarily due to the high prevalence of vascular diseases, the ageing population, and advanced healthcare infrastructure. The U.S., in particular, has a well-established market for peripheral interventions, driven by a high demand for minimally invasive procedures and ongoing advancements in medical technologies.

Europe also plays a crucial role in the market, with countries like Germany, the UK, and France focusing on the adoption of innovative peripheral intervention devices. The European market benefits from strong healthcare policies, increasing awareness of vascular diseases, and expanding access to advanced treatments. In contrast, the Asia Pacific region is experiencing the fastest growth, fueled by a large patient population, improving healthcare facilities, and increasing disposable incomes in countries like China, India, and Japan. As the prevalence of lifestyle-related diseases rises in these nations, there is a growing demand for cost-effective, minimally invasive treatment options. In Latin America and the Middle East & Africa, the peripheral interventions market is gradually expanding, as healthcare systems improve and awareness of vascular conditions increases, creating new opportunities for market growth and innovation in these regions.

Peripheral Interventions Market- Competitive Landscape:

The competitive landscape of the peripheral interventions market is characterized by the presence of several established players, alongside emerging companies focusing on innovation and new product development. Market participants compete based on product quality, technological advancements, and strategic partnerships. Leading companies are continually working to enhance their product offerings with features such as drug-eluting stents, bioresorbable stents, and advanced catheter technologies to improve patient outcomes and reduce the risk of complications. These innovations aim to provide safer, more effective, and longer-lasting solutions for treating peripheral vascular diseases. Additionally, companies are expanding their market presence through mergers, acquisitions, and collaborations with healthcare institutions to increase their geographical reach and access new patient populations. Another key strategy is the emphasis on cost-effective solutions, particularly in emerging markets, where affordability and accessibility are critical factors in driving adoption. Regulatory approvals and compliance with stringent safety standards are also key differentiators in this competitive landscape, as companies must navigate complex regulatory environments to introduce new products. The competitive dynamics are further shaped by ongoing clinical trials, research, and development activities, which focus on enhancing device performance and expanding the indications for peripheral interventions. This landscape continues to evolve as the demand for advanced, minimally invasive treatments rises globally, particularly in regions with a growing burden of vascular diseases.

Recent Developments:

  • In April 2024, Abbott's breakthrough dissolving stent, the Esprit BTK System, received FDA approval for treating arteries below the knee, offering a new, effective solution for patients with chronic limb-threatening ischemia (CLTI) and peripheral artery disease (PAD). This innovative device, which dissolves over time, outperforms traditional balloon angioplasty in improving outcomes and reducing disease progression.
  • In June 2024, Philips launched the Duo Venous Stent System, a groundbreaking medical device designed to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). This device, which received premarket approval from the FDA, addresses challenges in venous anatomy by combining two stents, Duo Hybrid and Duo Extend, offering a differential design to accommodate vessel curvature and minimize stent complications. The system is part of Philips' broader strategy to enhance CVI treatment through innovative vascular technologies.
  • In November 2024, Solaris Endovascular, a new vascular stent graft company, was launched in the United States. The company is introducing innovative technologies aimed at improving patient outcomes in the treatment of peripheral artery disease (PAD) and dialysis access. The launch marks a significant milestone as Solaris aims to address critical gaps in vascular care, with a focus on high-quality, durable solutions to prevent restenosis and improve long-term vessel patency.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERIPHERAL INTERVENTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Boston Scientific
  • Medtronic
  • Cook Medical
  • Cordis
  • Terumo Corporation
  • Johnson & Johnson
  • Teleflex
  • B. Braun Melsungen
  • Penumbra, Inc.
  • Endologix
  • Merit Medical Systems
  • Philips Healthcare
  • AngioDynamics
  • Siemens Healthineers
  • Others

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Stents
  • Catheters
  • Guidewires
  • Balloons
  • Vascular Closure Devices

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY PROCEDURE - MARKET ANALYSIS, 2019 - 2032

  • Angioplasty
  • Stenting
  • Atherectomy
  • Thrombolysis

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Peripheral Interventions Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Peripheral Interventions Market Snippet by Product Type
    • 2.1.2. Peripheral Interventions Market Snippet by Procedure
    • 2.1.3. Peripheral Interventions Market Snippet by End-Use
    • 2.1.4. Peripheral Interventions Market Snippet by Country
    • 2.1.5. Peripheral Interventions Market Snippet by Region
  • 2.2. Competitive Insights

3. Peripheral Interventions Key Market Trends

  • 3.1. Peripheral Interventions Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Peripheral Interventions Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Peripheral Interventions Market Opportunities
  • 3.4. Peripheral Interventions Market Future Trends

4. Peripheral Interventions Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Peripheral Interventions Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Peripheral Interventions Market Landscape

  • 6.1. Peripheral Interventions Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Peripheral Interventions Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Stents
    • 7.1.3. Catheters
    • 7.1.4. Guidewires
    • 7.1.5. Balloons
    • 7.1.6. Vascular Closure Devices

8. Peripheral Interventions Market - By Procedure

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
    • 8.1.2. Angioplasty
    • 8.1.3. Stenting
    • 8.1.4. Atherectomy
    • 8.1.5. Thrombolysis

9. Peripheral Interventions Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Specialty Clinics

10. Peripheral Interventions Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Peripheral Interventions Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Peripheral Interventions Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Peripheral Interventions Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Peripheral Interventions Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Peripheral Interventions Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Peripheral Interventions Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott
    • 11.2.2. Boston Scientific
    • 11.2.3. Medtronic
    • 11.2.4. Cook Medical
    • 11.2.5. Cordis
    • 11.2.6. Terumo Corporation
    • 11.2.7. Johnson & Johnson
    • 11.2.8. Teleflex
    • 11.2.9. B. Braun Melsungen
    • 11.2.10. Penumbra, Inc.
    • 11.2.11. Endologix
    • 11.2.12. Merit Medical Systems
    • 11.2.13. Philips Healthcare
    • 11.2.14. AngioDynamics
    • 11.2.15. Siemens Healthineers
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us